BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38335705)

  • 21. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress on engineered micro/nanomaterials mediated modulation of gut microbiota for treating inflammatory bowel disease.
    Kan L; Zheng Z; Fu W; Ma Y; Wang W; Qian H; Xu L
    J Control Release; 2024 Jun; 370():43-65. PubMed ID: 38608876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
    Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next generation probiotics: Engineering live biotherapeutics.
    Murali SK; Mansell TJ
    Biotechnol Adv; 2024; 72():108336. PubMed ID: 38432422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
    Naseer M; Poola S; Ali S; Samiullah S; Tahan V
    Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From Pre- and Probiotics to Post-Biotics: A Narrative Review.
    Scarpellini E; Rinninella E; Basilico M; Colomier E; Rasetti C; Larussa T; Santori P; Abenavoli L
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
    Celiberto LS; Bedani R; Rossi EA; Cavallini DC
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biotics in pediatrics: a short overview.
    Panelli S; D'Auria E; Papaleo S; Alvaro A; Bandi C; Comandatore F; Zuccotti G
    Minerva Pediatr (Torino); 2022 Dec; 74(6):682-687. PubMed ID: 35822582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional Foods.
    Vitetta L; Oldfield D; Sali A
    Front Biosci (Elite Ed); 2024 May; 16(2):13. PubMed ID: 38939911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Innovations in Non-dairy Prebiotics and Probiotics: Physiological Potential, Applications, and Characterization.
    Khan FF; Sohail A; Ghazanfar S; Ahmad A; Riaz A; Abbasi KS; Ibrahim MS; Uzair M; Arshad M
    Probiotics Antimicrob Proteins; 2023 Apr; 15(2):239-263. PubMed ID: 36063353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome.
    Luzzi A; Briata IM; Di Napoli I; Giugliano S; Di Sabatino A; Rescigno M; Cena H
    Clin Nutr; 2024 Jun; 43(6):1433-1446. PubMed ID: 38704983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.
    Scaldaferri F; Gerardi V; Lopetuso LR; Del Zompo F; Mangiola F; Boškoski I; Bruno G; Petito V; Laterza L; Cammarota G; Gaetani E; Sgambato A; Gasbarrini A
    Biomed Res Int; 2013; 2013():435268. PubMed ID: 23991417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
    Eindor-Abarbanel A; Healey GR; Jacobson K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.
    Patel R; DuPont HL
    Clin Infect Dis; 2015 May; 60 Suppl 2(Suppl 2):S108-21. PubMed ID: 25922396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biotics: An emerging food supplement for health improvement in the era of immune modulation.
    Revankar NA; Negi PS
    Nutr Clin Pract; 2024 Apr; 39(2):311-329. PubMed ID: 37466413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiota on biotics: probiotics, prebiotics, and synbiotics to optimize growth and metabolism.
    Edwards PT; Kashyap PC; Preidis GA
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G382-G390. PubMed ID: 32755308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiome-targeted therapies for Alzheimer's disease.
    Zhang T; Gao G; Kwok LY; Sun Z
    Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consumer's acceptability and health consciousness of probiotic and prebiotic of non-dairy products.
    Cosme F; Inês A; Vilela A
    Food Res Int; 2022 Jan; 151():110842. PubMed ID: 34980381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.